NILO Therapeutics
NILO Therapeutics is a startup headquartered in New York, United States, founded in 2024. It has raised at least $9.6m in outside funding, according to its filings with the US Securities and Exchange Commission (Form D), which puts it at the early stage.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Funding
NILO Therapeutics has raised at least $9.6m in outside funding, according to its Form D filings with the US Securities and Exchange Commission. Form D figures are a minimum: not every round is filed.
R&D ecosystem
NILO Therapeutics sits inside the New York and New Jersey R&D ecosystem in the Global R&D Labs Directory.
Other startups in New York
Related
- Innovation profile of New York
- United States: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does NILO Therapeutics do?
NILO Therapeutics is classed in biotechnology in its filings with the US Securities and Exchange Commission.
How much has NILO Therapeutics raised?
At least $9.6m, according to its Form D filings with the US Securities and Exchange Commission.
Where is NILO Therapeutics based?
NILO Therapeutics is headquartered in New York, United States.
When was NILO Therapeutics founded?
NILO Therapeutics was founded in 2024.
Source record: SEC EDGAR (Form D filings).
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.